Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatitis C | 2 | 2022 | 151 | 1.100 |
Why?
|
| Pregnancy Complications | 3 | 2020 | 377 | 1.020 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 479 | 0.880 |
Why?
|
| Hepatitis C, Chronic | 2 | 2022 | 88 | 0.840 |
Why?
|
| Pregnancy Outcome | 5 | 2019 | 193 | 0.830 |
Why?
|
| Medicaid | 6 | 2022 | 362 | 0.710 |
Why?
|
| Developmental Disabilities | 2 | 2020 | 116 | 0.710 |
Why?
|
| Antiviral Agents | 3 | 2022 | 322 | 0.680 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 1100 | 0.680 |
Why?
|
| Prenatal Care | 3 | 2018 | 170 | 0.640 |
Why?
|
| Community Health Services | 1 | 2018 | 128 | 0.530 |
Why?
|
| Medication Adherence | 1 | 2018 | 202 | 0.510 |
Why?
|
| Premature Birth | 3 | 2016 | 112 | 0.510 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 436 | 0.490 |
Why?
|
| Inpatients | 1 | 2018 | 303 | 0.470 |
Why?
|
| Medicare Assignment | 1 | 2014 | 2 | 0.450 |
Why?
|
| Medicare Part A | 1 | 2014 | 7 | 0.450 |
Why?
|
| Massachusetts | 6 | 2020 | 2077 | 0.440 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2014 | 42 | 0.430 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 42 | 0.430 |
Why?
|
| Pregnancy | 7 | 2020 | 2330 | 0.410 |
Why?
|
| Urinary Tract Infections | 1 | 2014 | 90 | 0.410 |
Why?
|
| Cross Infection | 1 | 2014 | 162 | 0.390 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 563 | 0.350 |
Why?
|
| Hospitalization | 1 | 2018 | 1359 | 0.340 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 732 | 0.340 |
Why?
|
| Socioeconomic Factors | 5 | 2018 | 777 | 0.300 |
Why?
|
| Hepacivirus | 2 | 2022 | 141 | 0.300 |
Why?
|
| Young Adult | 6 | 2019 | 4683 | 0.260 |
Why?
|
| Female | 13 | 2022 | 32793 | 0.250 |
Why?
|
| United States | 8 | 2022 | 7828 | 0.240 |
Why?
|
| Adult | 10 | 2019 | 16784 | 0.230 |
Why?
|
| Retrospective Studies | 6 | 2019 | 6631 | 0.230 |
Why?
|
| Humans | 17 | 2022 | 63299 | 0.230 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2019 | 713 | 0.220 |
Why?
|
| Infant, Newborn | 2 | 2019 | 1355 | 0.210 |
Why?
|
| Drug Therapy, Combination | 2 | 2022 | 463 | 0.210 |
Why?
|
| Infant | 2 | 2019 | 1649 | 0.200 |
Why?
|
| Analgesics, Opioid | 2 | 2019 | 536 | 0.200 |
Why?
|
| Cohort Studies | 2 | 2019 | 2570 | 0.180 |
Why?
|
| Hypoglycemia | 1 | 2022 | 65 | 0.180 |
Why?
|
| Pediatric Obesity | 1 | 2021 | 109 | 0.150 |
Why?
|
| Risk | 1 | 2019 | 377 | 0.150 |
Why?
|
| International Classification of Diseases | 1 | 2019 | 137 | 0.150 |
Why?
|
| Uridine Monophosphate | 1 | 2018 | 9 | 0.150 |
Why?
|
| Fluorenes | 1 | 2018 | 14 | 0.150 |
Why?
|
| Medication Therapy Management | 1 | 2018 | 21 | 0.150 |
Why?
|
| Pediatrics | 1 | 2021 | 254 | 0.140 |
Why?
|
| Postpartum Period | 1 | 2020 | 195 | 0.140 |
Why?
|
| Benzimidazoles | 1 | 2018 | 54 | 0.140 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 81 | 0.140 |
Why?
|
| Motivational Interviewing | 1 | 2018 | 43 | 0.140 |
Why?
|
| Infant, Premature | 1 | 2019 | 184 | 0.140 |
Why?
|
| Adolescent | 5 | 2019 | 6238 | 0.140 |
Why?
|
| Hydrocodone | 1 | 2017 | 7 | 0.140 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 730 | 0.140 |
Why?
|
| Drug and Narcotic Control | 1 | 2017 | 28 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2022 | 621 | 0.130 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 168 | 0.130 |
Why?
|
| Administration, Oral | 1 | 2018 | 369 | 0.130 |
Why?
|
| Insurance Claim Review | 1 | 2016 | 76 | 0.130 |
Why?
|
| Child | 3 | 2021 | 4522 | 0.120 |
Why?
|
| Preconception Care | 1 | 2016 | 23 | 0.120 |
Why?
|
| Pain | 1 | 2019 | 406 | 0.120 |
Why?
|
| Health Status Indicators | 1 | 2016 | 93 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 695 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2018 | 753 | 0.110 |
Why?
|
| Health Status Disparities | 1 | 2016 | 145 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 735 | 0.110 |
Why?
|
| Reimbursement, Incentive | 1 | 2014 | 29 | 0.110 |
Why?
|
| Cost Savings | 1 | 2014 | 54 | 0.110 |
Why?
|
| Male | 6 | 2022 | 29823 | 0.110 |
Why?
|
| Hospital Costs | 1 | 2014 | 126 | 0.100 |
Why?
|
| Health Status | 1 | 2015 | 435 | 0.100 |
Why?
|
| Health Behavior | 1 | 2015 | 466 | 0.100 |
Why?
|
| Risk Factors | 2 | 2018 | 5343 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2018 | 791 | 0.090 |
Why?
|
| Length of Stay | 1 | 2014 | 811 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2014 | 442 | 0.080 |
Why?
|
| Middle Aged | 4 | 2019 | 17555 | 0.070 |
Why?
|
| Drug Combinations | 2 | 2018 | 165 | 0.070 |
Why?
|
| Infant, Low Birth Weight | 2 | 2015 | 60 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 5447 | 0.050 |
Why?
|
| Aged | 2 | 2018 | 14396 | 0.050 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2022 | 62 | 0.050 |
Why?
|
| Healthy Lifestyle | 1 | 2021 | 28 | 0.040 |
Why?
|
| Smoking | 2 | 2016 | 865 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2022 | 483 | 0.040 |
Why?
|
| Overweight | 1 | 2021 | 250 | 0.040 |
Why?
|
| Sustained Virologic Response | 1 | 2018 | 10 | 0.040 |
Why?
|
| Sofosbuvir | 1 | 2018 | 17 | 0.040 |
Why?
|
| Ribavirin | 1 | 2018 | 23 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2018 | 61 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2018 | 200 | 0.040 |
Why?
|
| Controlled Substances | 1 | 2017 | 5 | 0.030 |
Why?
|
| Viral Load | 1 | 2018 | 231 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 863 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 860 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2018 | 276 | 0.030 |
Why?
|
| Psychiatry | 1 | 2018 | 126 | 0.030 |
Why?
|
| Health Promotion | 1 | 2021 | 494 | 0.030 |
Why?
|
| Genotype | 1 | 2018 | 664 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 462 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2018 | 488 | 0.030 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2016 | 43 | 0.030 |
Why?
|
| Rhode Island | 1 | 2015 | 98 | 0.030 |
Why?
|
| Life Change Events | 1 | 2015 | 66 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2015 | 162 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2016 | 206 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 935 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 314 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 1377 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2015 | 469 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1560 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 2076 | 0.020 |
Why?
|
| Obesity | 1 | 2016 | 1230 | 0.020 |
Why?
|